case_id	host_age	host_sex	organism	isolate_id	gene_name_1	body_product	host_disease	sequenced_by	vaccine_name	complications	gene_symbol_1	host_age_unit	hot_subject_id	other_host_sex	other_organism	travel_history	anatomical_part	fasta_file_name	sequencing_date	antiviral_therapy	fasta_header_name	host_health_state	assembly_accession	lineage_clade_name	other_body_product	signs_and_symptoms	symptom_onset_date	anatomical_material	assay_target_name_1	biosample_accession	host_health_outcome	purpose_of_sampling	sample_collected_by	vaccination_history	geo_loc_name_country	host_scientific_name	other_anatomical_part	purpose_of_sequencing	sequencing_assay_type	sequencing_instrument	environmental_material	sample_collection_date	bioinformatics_protocol	depth_of_coverage_value	host_vaccination_status	sequence_read_accession	other_lineage_clade_name	breadth_of_coverage_value	diagnostic_pcr_Ct_value_1	diagnostic_pcr_protocol_1	other_anatomical_material	other_host_health_outcome	other_sample_collected_by	host_health_status_details	other_host_scientific_name	prior_Mpox_treatment_agent	reference_genome_accession	other_purpose_of_sequencing	other_sequencing_instrument	other_environmental_material	prior_Mpox_infection_isolate	specimen_collector_sample_id	other_host_health_status_details	host_residence_geo_loc_name_country	geo_loc_name_state_province_territory	pre-existing_conditions_and_risk_factors	location_of_exposure_geo_loc_name_country	prior_antiviral_treatment_during_prior_Mpox_infection
MPOX-001	25	Female	Mpox virus	MPOX-001	MPX (orf B6R)	Breast Milk	Mpox	mpox_sequenced_by_001	mpox_vaccine_name_001	Bronchopneumonia	opg001 gene (MPOX)	Month	mpox_hot_subject_id_001	mpox_other_host_sex_001	mpox_other_organism_001	mpox_travel_history_001	Anus	mpox_001.fasta	2024-01-15	mpox_antiviral_therapy_001	>mpox_001_sequence	Asymptomatic	SAMN100000	Mpox virus clade I	mpox_other_body_product_001	mpox_signs_and_symptoms_001	2024-01-15	Blood	mpox_assay_target_name_1_001	NZ_100000	Deceased	Cluster/Outbreak investigation	Programa Nacional de Controlo da Malária (Angola)	mpox_vaccination_history_001	Algeria	Homo sapiens	mpox_other_anatomical_part_001	Baseline surveillance (random sampling)	Amplicon sequencing assay	Illumina	Animal carcass	2024-01-15	mpox_bioinformatics_protocol_001	50	Fully Vaccinated	CP100000	mpox_other_lineage_clade_name_001	mpox_breadth_of_coverage_value_001	mpox_diagnostic_pcr_Ct_value_1_001	mpox_diagnostic_pcr_protocol_1_001	mpox_other_anatomical_material_001	mpox_other_host_health_outcome_001	mpox_other_sample_collected_by_001	Hospitalized	mpox_other_host_scientific_name_001	mpox_prior_Mpox_treatment_agent_001	SAMN100000	mpox_other_purpose_of_sequencing_001	mpox_other_sequencing_instrument_001	mpox_other_environmental_material_001	mpox_prior_Mpox_infection_isolate_001	SPEC-MPOX-001	mpox_other_host_health_status_details_001	Algeria	Adrar	mpox_pre-existing_conditions_and_risk_factors_001	Afghanistan	mpox_prior_antiviral_treatment_during_prior_Mpox_infection_001
MPOX-002	35	Male	Not Applicable	MPOX-002	OPV (orf 17L)	Feces	Not Applicable	mpox_sequenced_by_002	mpox_vaccine_name_002	Corneal infection	opg002 gene (MPOX)	Year	mpox_hot_subject_id_002	mpox_other_host_sex_002	mpox_other_organism_002	mpox_travel_history_002	Perianal skin	mpox_002.fasta	2024-01-22	mpox_antiviral_therapy_002	>mpox_002_sequence	Deceased	CP101000	Mpox virus clade Ia	mpox_other_body_product_002	mpox_signs_and_symptoms_002	2024-01-22	Blood Clot	mpox_assay_target_name_1_002	CP101000	Deteriorating	Diagnostic testing	Instituto Nacional de Investigação em Saúde (Angola)	mpox_vaccination_history_002	Angola	Not Applicable	mpox_other_anatomical_part_002	Targeted surveillance (non-random sampling)	16S ribosomal gene sequencing assay	Illumina Genome Analyzer	Bedding (Bed linen)	2024-01-22	mpox_bioinformatics_protocol_002	60	Partially Vaccinated	CP101000	mpox_other_lineage_clade_name_002	mpox_breadth_of_coverage_value_002	mpox_diagnostic_pcr_Ct_value_1_002	mpox_diagnostic_pcr_protocol_1_002	mpox_other_anatomical_material_002	mpox_other_host_health_outcome_002	mpox_other_sample_collected_by_002	Hospitalized (Non-ICU)	mpox_other_host_scientific_name_002	mpox_prior_Mpox_treatment_agent_002	SRR101000	mpox_other_purpose_of_sequencing_002	mpox_other_sequencing_instrument_002	mpox_other_environmental_material_002	mpox_prior_Mpox_infection_isolate_002	SPEC-MPOX-002	mpox_other_host_health_status_details_002	Angola	Aïn Defla	mpox_pre-existing_conditions_and_risk_factors_002	Albania	mpox_prior_antiviral_treatment_during_prior_Mpox_infection_002
MPOX-003	45	Not Applicable	Missing	MPOX-003	OPHA (orf B2R)	Fluid (discharge)	Missing	mpox_sequenced_by_003	mpox_vaccine_name_003	Delayed wound healing (lesion healing)	opg003 gene (MPOX)	Not Applicable	mpox_hot_subject_id_003	mpox_other_host_sex_003	mpox_other_organism_003	mpox_travel_history_003	Arm	mpox_003.fasta	2024-01-29	mpox_antiviral_therapy_003	>mpox_003_sequence	Healthy	SRR102000	Mpox virus clade Ib	mpox_other_body_product_003	mpox_signs_and_symptoms_003	2024-01-29	Blood Serum	mpox_assay_target_name_1_003	CP102000	Recovered	Research	Agostinho Neto University, Faculty of Medicine (Angola)	mpox_vaccination_history_003	Benin	Missing	mpox_other_anatomical_part_003	Priority surveillance project	Whole genome sequencing assay	Illumina Genome Analyzer II	Clothing	2024-01-29	mpox_bioinformatics_protocol_003	70	Not Vaccinated	SAMN102000	mpox_other_lineage_clade_name_003	mpox_breadth_of_coverage_value_003	mpox_diagnostic_pcr_Ct_value_1_003	mpox_diagnostic_pcr_protocol_1_003	mpox_other_anatomical_material_003	mpox_other_host_health_outcome_003	mpox_other_sample_collected_by_003	Hospitalized (ICU)	mpox_other_host_scientific_name_003	mpox_prior_Mpox_treatment_agent_003	NZ_102000	mpox_other_purpose_of_sequencing_003	mpox_other_sequencing_instrument_003	mpox_other_environmental_material_003	mpox_prior_Mpox_infection_isolate_003	SPEC-MPOX-003	mpox_other_host_health_status_details_003	Benin	Aïn Témouchent	mpox_pre-existing_conditions_and_risk_factors_003	Algeria	mpox_prior_antiviral_treatment_during_prior_Mpox_infection_003
